| Price | 10.00p on 05-12-2025 at 19:40:05 |
|---|---|
| Change | 0.20p 1.9% |
| Buy | 10.50p |
| Sell | 9.50p |
| Last Trade: | Buy 3,000.00 at 10.70p |
| Day's Volume: | 249,302 |
| Last Close: | 10.70p |
| Open: | 10.70p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 10.00p - 10.70p |
| 52wk Range: | 5.25p - 10.90p |
| Market Capitalisation: | £657.13m |
| VWAP: | 10.1936p |
| Shares in Issue: | 6.14b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 3,000 | 10.70p | Suspected BUY Trade |
16:35:08 - 05-Dec-25 |
| Buy* | 20,000 | 10.50p | Ordinary |
15:39:06 - 05-Dec-25 |
| Sell* | 17,801 | 9.8255p | Ordinary |
15:37:07 - 05-Dec-25 |
| Buy* | 2,500 | 10.70p | Suspected BUY Trade |
14:00:08 - 05-Dec-25 |
| Buy* | 2,000 | 10.70p | Suspected BUY Trade |
11:00:19 - 05-Dec-25 |
| Buy* | 2,000 | 10.70p | Suspected BUY Trade |
09:00:18 - 05-Dec-25 |
| Unknown* | 100,000 | 10.1666p | Ordinary |
08:47:42 - 05-Dec-25 |
| Buy* | 50,000 | 10.1666p | Ordinary |
08:46:57 - 05-Dec-25 |
| Buy* | 50,000 | 10.1666p | Ordinary |
08:46:37 - 05-Dec-25 |
| Buy* | 1 | 10.335p | Ordinary |
08:15:08 - 05-Dec-25 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Nov 2025 7:22 am | RNS | Company to Evaluate Dual Listing on HKEX |
| 30th Oct 2025 7:00 am | RNS | G308 Phase III Year 2 Patient Screening Starts |
| 29th Oct 2025 7:00 am | RNS | Warrant Exercise and Paydown of Debt |
| 16th Oct 2025 7:00 am | RNS | Further progress in Phase I/IIa PROTECT trial |
| 31st Jul 2025 7:00 am | RNS-R | Grass MATA MPL Publications in Allergy Journal |
| 21st Jul 2025 7:00 am | RNS | Trading update for the year ended 30 June 2025 |
| 11th Jul 2025 7:00 am | RNS | PDMR Dealings |
| 13th Jun 2025 7:00 am | RNS-R | Allergy Therapeutics presents findings at EAACI |
| 10th Jun 2025 7:04 am | RNS-R | EAACI Early Career Research Award |
| 31st Mar 2025 7:00 am | RNS | Interim Results for six months ended 31 Dec 2024 |
